Health Bio-Pharmaceutical (600380.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 887 million yuan, a year-on-year decrease of 18.76%.

Zhitong Finance APP News, Jiankangyuan (600380.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 9.671 billion yuan, a year-on-year decrease of 15.74%; net profit attributable to the parent company was 887 million yuan, a year-on-year decrease of 18.76%; net profit after deducting non-recurring gains and losses was 846 million yuan, a year-on-year decrease of 20.02%; basic earnings per share were 0.48 yuan.